索宝蛋白(603231) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was CNY 391,920,304.59, a decrease of 0.26% compared to the same period last year[4] - Net profit attributable to shareholders increased by 22.41% to CNY 44,476,092.41, while the net profit after deducting non-recurring gains and losses rose by 26.14% to CNY 41,860,638.10[4] - The basic earnings per share for the period was CNY 0.23, reflecting a growth of 21.05% year-on-year[6] - The company reported a significant increase in net profit despite a slight decline in operating revenue, indicating improved operational efficiency[4] - Total operating revenue for Q1 2025 was ¥391,920,304.59, a slight decrease of 0.26% compared to ¥392,958,453.13 in Q1 2024[16] - Net profit for Q1 2025 increased by 22.43% to ¥44,476,092.41 compared to ¥36,333,953.10 in Q1 2024[17] - Basic and diluted earnings per share for Q1 2025 were both ¥0.23, up from ¥0.19 in Q1 2024[18] - The company’s total comprehensive income for Q1 2025 was ¥44,479,985.44, compared to ¥36,333,953.10 in Q1 2024[18] Assets and Liabilities - The company's total assets at the end of the reporting period were CNY 2,137,494,093.98, an increase of 2.53% from the end of the previous year[6] - As of March 31, 2025, the total assets of the company amounted to RMB 2,137,494,093.98, an increase from RMB 2,084,649,913.94 as of December 31, 2024, reflecting a growth of approximately 2.53%[12] - The company's current assets totaled RMB 1,328,511,118.23, compared to RMB 1,296,925,659.65 at the end of 2024, indicating an increase of about 2.63%[13] - The total liabilities of the company were RMB 218,595,907.46, up from RMB 210,231,712.86, reflecting an increase of about 1.7%[14] - The owner's equity reached RMB 1,918,898,186.52, compared to RMB 1,874,418,201.08, indicating a growth of approximately 2.37%[15] Cash Flow - The net cash flow from operating activities was negative at CNY -55,884,419.94, primarily due to increased raw material purchases[8] - Cash flow from operating activities showed a net outflow of ¥55,884,419.94 in Q1 2025, compared to a net inflow of ¥18,553,701.83 in Q1 2024[20] - Cash flow from investing activities resulted in a net outflow of ¥141,413,268.38 in Q1 2025, compared to a larger outflow of ¥675,349,522.92 in Q1 2024[21] - Cash and cash equivalents decreased to RMB 124,349,141.98 from RMB 320,026,347.41, representing a decline of approximately 61.1%[12] - Cash and cash equivalents at the end of Q1 2025 were ¥124,344,141.98, down from ¥350,787,028.79 at the end of Q1 2024[21] Shareholder Information - The top ten shareholders held a total of 43.2% of the company's shares, with Shandong Wandefu Industrial Group Co., Ltd. being the largest shareholder[10] - There were no significant changes in the top 10 shareholders or their shareholding status during the reporting period[12] Other Information - The company received government subsidies amounting to CNY 307,430.60 during the reporting period[7] - Non-recurring gains and losses totaled CNY 2,615,454.31, with significant contributions from fair value changes of financial assets[8] - The company has ongoing investments in new technologies and market expansion strategies, although specific details were not provided in the content[12] - The company reported other income of ¥176,541.05 in Q1 2025, an increase from ¥124,315.89 in Q1 2024[17] - The company experienced a foreign exchange impact of ¥1,740,972.57 on cash and cash equivalents in Q1 2025[21] - The company's cash flow from operating activities showed a net outflow of ¥55,884,419.94 in Q1 2025, compared to a net inflow of ¥18,553,701.83 in Q1 2024[20]